DJIA 17,550.69 -47.51 -0.27%
NASDAQ 5,105.55 -9.84 -0.19%
S&P 500 2,093.32 -4.72 -0.22%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

55.30 1.34 (2.48%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $55.30 2.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $54.18
Previous Close $53.96
Daily Range $53.25 - $56.13
52-Week Range $29.17 - $77.80
Market Cap $6.6B
P/E Ratio -269.80
Dividend (Yield) $0.00 (0.0%)
Volume 1,951,948
Average Daily Volume 2,401,660
Current FY EPS -$0.26

Sector

Healthcare

Industry

Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary

Isis' News-Filled Week

The biotech announces a new partnership, clinical trial results, and earnings over the course of two days.

Isis Pharmaceuticals (ISIS) Misses Earnings Estimates in Q2 - Tale of the Tape

Will Isis Pharmaceuticals (ISIS) Beat Q2 Earnings Estimates? - Analyst Blog

Isis Pharma 8-K Filing Shows Company Enters Agreement with Astrazeneca To Discover And Develop Antis

Isis Pharma 8-K Filing Shows Company Enters Agreement with Astrazeneca To Discover And Develop Antisense Drugs FOr Cardiovascular, Metabolic And Renal Disease

AstraZeneca, Isis Pharmaceuticals to Collaborate to Develop Antisense Drugs for Cardiovascular, Meta

AstraZeneca, Isis Pharmaceuticals to Collaborate to Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases

AstraZeneca Beats on Q2 Earnings, Revises Revenue View - Analyst Blog

AstraZeneca Beats on Q2 Earnings, Revises Revenue View - Analyst Blog

Glaxo Up on Q2 Earnings Beat, Revenues Rise, View Same - Analyst Blog

Vertex Posts Wider Y/Y Loss but Raises Kalydeco Outlook - Analyst Blog

United Therapeutics Misses on Q2 Earnings & Revenues - Analyst Blog

ISIS Pharmaceuticals: Another Entry Point

See More ISIS News...

ISIS's Top Competitors

ISIS $55.30 (2.48%)
Current stock: ISIS
AMGN $174.80 (-0.45%)
Current stock: AMGN
GILD $118.87 (-0.61%)
Current stock: GILD
BIIB $330.38 (1.85%)
Current stock: BIIB